5906 related articles for article (PubMed ID: 3081269)
1. In vivo and in vitro anticancer activity of the structurally novel and highly potent antibiotic CI-940 and its hydroxy analog (PD 114,721).
Roberts BJ; Hamelehle KL; Sebolt JS; Leopold WR
Cancer Chemother Pharmacol; 1986; 16(2):95-101. PubMed ID: 3081269
[TBL] [Abstract][Full Text] [Related]
2. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of mitoxantrone against murine experimental tumors: comparative analysis against various antitumor antibiotics.
Fujimoto S; Ogawa M
Cancer Chemother Pharmacol; 1982; 8(2):157-62. PubMed ID: 7105379
[TBL] [Abstract][Full Text] [Related]
4. Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias.
Showalter HD; Johnson JL; Hoftiezer JM; Turner WR; Werbel LM; Leopold WR; Shillis JL; Jackson RC; Elslager EF
J Med Chem; 1987 Jan; 30(1):121-31. PubMed ID: 3806589
[TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor activity of 6-benzyl-1,3-benzodioxole derivatives against the P388, L1210, B16, and M5076 murine models.
Jurd L; Narayanan VL; Paull KD
J Med Chem; 1987 Oct; 30(10):1752-6. PubMed ID: 2821258
[TBL] [Abstract][Full Text] [Related]
6. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
Guilbaud N; Kraus-Berthier L; Saint-Dizier D; Rouillon MH; Jan M; Burbridge M; Visalli M; Bisagni E; Pierré A; Atassi G
Cancer Chemother Pharmacol; 1996; 38(6):513-21. PubMed ID: 8823492
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of the structurally novel antibiotic Cl-920 and its analogues.
Leopold WR; Shillis JL; Mertus AE; Nelson JM; Roberts BJ; Jackson RC
Cancer Res; 1984 May; 44(5):1928-32. PubMed ID: 6546897
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
9. Antitumour activity of some cyclophosphazenes.
Labarre JF; Faucher JP; Levy G; Sournies F; Cros S; François G
Eur J Cancer (1965); 1979 May; 15(5):637-43. PubMed ID: 510331
[No Abstract] [Full Text] [Related]
10. The effectiveness of the anthracycline analog 4'-epidoxorubicin in the treatment of experimental tumors: a review.
Goldin A; Venditti JM; Geran R
Invest New Drugs; 1985; 3(1):3-21. PubMed ID: 3886588
[TBL] [Abstract][Full Text] [Related]
11. Experimental antitumor activity of BMY-28090, a new antitumor antibiotic.
Schurig JE; Bradner WT; Basler GA; Rose WC
Invest New Drugs; 1989 Jul; 7(2-3):173-8. PubMed ID: 2793369
[TBL] [Abstract][Full Text] [Related]
12. Anthrapyrazoles, a new class of intercalating agents with high-level, broad spectrum activity against murine tumors.
Leopold WR; Nelson JM; Plowman J; Jackson RC
Cancer Res; 1985 Nov; 45(11 Pt 1):5532-9. PubMed ID: 4053027
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity and cross-resistance of carmethizole hydrochloride in preclinical models in mice.
Waud WR; Plowman J; Harrison SD; Dykes DJ; Anderson WK; Griswold DP
Cancer Chemother Pharmacol; 1992; 30(4):261-6. PubMed ID: 1322803
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of spergualin, a novel antitumor antibiotic.
Nishikawa K; Shibasaki C; Takahashi K; Nakamura T; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1986 Oct; 39(10):1461-6. PubMed ID: 3781914
[TBL] [Abstract][Full Text] [Related]
15. Activity of SC33428, a novel bishydrazone-bridged derivative of 4-demethoxydaunorubicin, against experimental tumors in mice.
Dawson KM
Cancer Res; 1983 Jun; 43(6):2880-3. PubMed ID: 6573953
[TBL] [Abstract][Full Text] [Related]
16. Treatment of mouse tumors with 7-con-O-methylnogarol and other analogs of the anthracycline antibiotic, nogalamycin.
Neil GL; Kuentzel SL; McGovren JP
Cancer Treat Rep; 1979; 63(11-12):1971-8. PubMed ID: 526931
[TBL] [Abstract][Full Text] [Related]
17. Effect of a delta 5-homo-aza-steroidal ester in P388 and L1210 murine leukemias.
Catsoulacos P; Camoutsis C; Wampler GL
Oncology; 1982; 39(1):59-60. PubMed ID: 7058047
[TBL] [Abstract][Full Text] [Related]
18. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
[TBL] [Abstract][Full Text] [Related]
19. [Models of preclinical studies of anthracyclines].
Fizames C
Pathol Biol (Paris); 1987 Jan; 35(1):41-8. PubMed ID: 3550611
[TBL] [Abstract][Full Text] [Related]
20. New designs in inorganic ring systems as anticancer drugs. Antitumor activity of the aziridino (ethylene-imino) derivatives (NPAz2)2NSOX with X = F, Az, Ph.
Labarre JF; Sournies F; Cros S; François G; van de Grampel JC; van der Huizen AA
Cancer Lett; 1981 Apr; 12(3):245-50. PubMed ID: 7260894
[No Abstract] [Full Text] [Related]
[Next] [New Search]